Inventor · disambiguated record
Sergei Gryaznov
Also filed as: GRYAZNOV SERGEI · GRYAZNOV SERGEI M
84 granted patents·27 pending applications·5,514 citations·filing 1993–2025
99Inventor score
Top patents by PatentIndex Score
111 records- 0199US5476925AOligodeoxyribonucleotides including 3'-aminonucleoside-phosphoramidate linkages and terminal 3'-amino groupsUNIV NORTHWESTERN·Filed 1995·Granted Dec 19, 1995·1.3k cites·4 claims
- 0298US7321029B22′-arabino-fluorooligonucleotide N3′→P5′ phosphoramidates: their synthesis and useGERON CORP·Filed 2001·Granted Jan 22, 2008·219 cites·20 claims
- 0398US6169170B1Oligonucleotide N3′→N5′Phosphoramidate DuplexesLYNX THERAPEUTICS INC·Filed 1997·Granted Jan 2, 2001·436 cites·13 claims
- 0497US5965720AOligonucleotide N3'→P5' phosphoramidatesLYNX THERAPEUTICS INC·Filed 1995·Granted Oct 12, 1999·267 cites·12 claims
- 0596US5591607AOligonucleotide N3→P5' phosphoramidates: triplex DNA formationLYNX THERAPEUTICS INC·Filed 1995·Granted Jan 7, 1997·264 cites·16 claims
- 0695US12030907B2Modified nucleoside phosphoramiditesJANSSEN BIOPHARMA INC·Filed 2021·Granted Jul 9, 2024·2 cites·18 claims
- 0795US10792251B2Liposomal particles, methods of making same and uses thereofUNIV NORTHWESTERN·Filed 2019·Granted Oct 6, 2020·11 cites·20 claims
- 0895US7494982B2Modified oligonucleotides for telomerase inhibitionGERON CORP·Filed 2004·Granted Feb 24, 2009·46 cites·2 claims
- 0995US6608036B1Oligonucleotide N3′→P5′ thiophosphoramidates: their synthesis and administration to treat neoplasmsGERON CORP·Filed 2000·Granted Aug 19, 2003·57 cites·19 claims
- 1095US5837835AOligonucleotide N3'-P5' phosphoramidates: hybridization and nuclease resistance propertiesLYNX THERAPEUTICS INC·Filed 1995·Granted Nov 17, 1998·155 cites·7 claims
- 1195US5726297AOligodeoxyribonucleotide N3' P5' phosphoramidatesLYNX THERAPEUTICS INC·Filed 1995·Granted Mar 10, 1998·262 cites·29 claims
- 1295US5476930ANon-enzymatic ligation of oligonucleotidesUNIV NORTHWESTERN·Filed 1995·Granted Dec 19, 1995·295 cites·7 claims
- 1394US9657296B2Modified oligonucleotides for telomerase inhibitionGERON CORP·Filed 2015·Granted May 23, 2017·10 cites·21 claims
- 1494US5684143AOligo-2'-fluoronucleotide N3'->P5' phosphoramidatesLYNX THERAPEUTICS INC·Filed 1996·Granted Nov 4, 1997·177 cites·16 claims
- 1594US5631135AOligonucleotide N3'→P5' phosphoramidates: hybridization and nuclease resistance propertiesLYNX THERAPEUTICS INC·Filed 1995·Granted May 20, 1997·164 cites·40 claims
- 1694US5599922AOligonucleotide N3'-P5' phosphoramidates: hybridization and nuclease resistance propertiesLYNX THERAPEUTICS INC·Filed 1994·Granted Feb 4, 1997·245 cites·32 claims
- 1793US9388415B2Modified oligonucleotides for telomerase inhibitionGERON CORP·Filed 2015·Granted Jul 12, 2016·8 cites·10 claims
- 1893US7563618B2Oligonucleotide conjugatesGERON CORP·Filed 2002·Granted Jul 21, 2009·42 cites·18 claims
- 1993US6835826B2Oligonucleotide N3′→P5′ Thiophosphoramidates: their synthesis and useGERON CORP·Filed 2003·Granted Dec 28, 2004·40 cites·2 claims
- 2092US10208310B2Anti-TNF compoundsEXICURE INC·Filed 2015·Granted Feb 19, 2019·17 cites·42 claims
- 2192US10182988B2Liposomal particles, methods of making same and uses thereofUNIV NORTHWESTERN·Filed 2014·Granted Jan 22, 2019·17 cites·18 claims
- 2292US7485717B2Synthesis of protected 3′-amino nucleoside monomersGERON CORP·Filed 2005·Granted Feb 3, 2009·26 cites·23 claims
- 2392US7138383B2Treating cancer using an oligonucleotide N3′->N5′ thiophosphoramidateGERON CORP·Filed 2004·Granted Nov 21, 2006·31 cites·5 claims
- 2492US5888737AAdaptor-based sequence analysisLYNX THERAPEUTICS INC·Filed 1997·Granted Mar 30, 1999·214 cites·36 claims
- 2591US11123294B2Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applicationsEXICURE OPERATING COMPANY·Filed 2019·Granted Sep 21, 2021·5 cites·33 claims
- 2691US10837018B2Spherical nucleic acid-based constructs as immunostimulatory agents for prophylactic and therapeutic useEXICURE INC·Filed 2018·Granted Nov 17, 2020·6 cites·20 claims
- 2791US8440635B2Oligonucleotide conjugatesGRYAZNOV SERGEI M·Filed 2009·Granted May 14, 2013·14 cites·21 claims
- 2891US7989603B22′-arabino-fluorooligonucleotide N3′-P5′ phosphoramidates: their synthesis and useGERON CORP·Filed 2007·Granted Aug 2, 2011·8 cites·5 claims
- 2990US11180524B2Modified nucleoside phosphoramiditesJANSSEN BIOPHARMA INC·Filed 2018·Granted Nov 23, 2021·4 cites·24 claims
- 3090US10760080B2Anti-TNF compoundsEXICURE INC·Filed 2019·Granted Sep 1, 2020·5 cites·19 claims
- 3190US9388416B2Modified oligonucleotides for telomerase inhibitionGERON CORP·Filed 2015·Granted Jul 12, 2016·5 cites·21 claims
- 3290US8748593B2Synthesis of protected 3′-amino nucleoside monomersGRYAZNOV SERGEI M·Filed 2008·Granted Jun 10, 2014·14 cites·7 claims
- 3390US5593826AEnzymatic ligation of 3'amino-substituted oligonucleotidesPERKIN ELMER CORP APPLIED BIOS·Filed 1993·Granted Jan 14, 1997·201 cites·18 claims
- 3489US10434064B2Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applicationsEXICURE INC·Filed 2015·Granted Oct 8, 2019·9 cites·10 claims
- 3589US9404112B2Modified oligonucleotides for telomerase inhibitionGRYAZNOV SERGEI·Filed 2012·Granted Aug 2, 2016·8 cites·15 claims
- 3689US5681943AMethod for covalently linking adjacent oligonucleotidesUNIV NORTHWESTERN·Filed 1995·Granted Oct 28, 1997·153 cites·23 claims
- 3788US11957788B2Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applicationsEXICURE OPERATING COMPANY·Filed 2021·Granted Apr 16, 2024·1 cites·20 claims
- 3888US8785409B2Compounds having anti-adhesive effects on cancer cellsGRYAZNOV SERGEI M·Filed 2008·Granted Jul 22, 2014·4 cites·23 claims
- 3988US8377644B22′-arabino-fluorooligonucleotide N3′→P5′ phosphoramidates: their synthesis and useGERON CORP·Filed 2011·Granted Feb 19, 2013·8 cites·9 claims
- 4088US5473060AOligonucleotide clamps having diagnostic applicationsLYNX THERAPEUTICS INC·Filed 1993·Granted Dec 5, 1995·95 cites·14 claims
- 4187US12428441B2Modified nucleoside phosphoramiditesJANSSEN BIOPHARMA INC·Filed 2024·Granted Sep 30, 2025·0 cites·18 claims
- 4287US10894963B2Spherical nucleic acid-based constructs as immunostimulatory agents for prophylactic and therapeutic useEXICURE INC·Filed 2014·Granted Jan 19, 2021·7 cites·16 claims
- 4387US8906615B22′-arabino-fluorooligonucleotide N3′→P5′ phosphoramidates: their synthesis and useGERON CORP·Filed 2013·Granted Dec 9, 2014·3 cites·10 claims
- 4487US2024300992A1Synthesis of Protected 3'-amino Nucleoside MonomersGERON CORP·Filed 2023·Application pending·0 cites
- 4586US8153604B2CNS-tumor treatment method and compositionDEEN DENNIS F·Filed 2007·Granted Apr 10, 2012·15 cites·8 claims
- 4686US2024382424A1Liposomal particles, methods of making same and uses thereofUNIV NORTHWESTERN·Filed 2023·Application pending·0 cites
- 4785US11883535B2Liposomal particles, methods of making same and uses thereofUNIV NORTHWESTERN·Filed 2020·Granted Jan 30, 2024·1 cites·23 claims
- 4885US6175002B1Adaptor-based sequence analysisLYNX THERAPEUTICS INC·Filed 1999·Granted Jan 16, 2001·94 cites·8 claims
- 4985US5571677AConvergent synthesis of branched and multiply connected macromomolecular structuresLYNX THERAPEUTICS INC·Filed 1995·Granted Nov 5, 1996·84 cites·20 claims
- 5085US5571903AAuto-ligating oligonucleotide compoundsLYNX THERAPEUTICS INC·Filed 1993·Granted Nov 5, 1996·61 cites·13 claims
Showing the top 50 of 111 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Sergei Gryaznov files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →